کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5892041 1153292 2011 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Bisphosphonates for postmenopausal osteoporosis
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی زیست شناسی تکاملی
پیش نمایش صفحه اول مقاله
Bisphosphonates for postmenopausal osteoporosis
چکیده انگلیسی
► Bisphosphonates reverse the key pathophysiological changes of postmenopausal osteoporosis. ► The bisphosphonates that have been licensed in many countries for postmenopausal osteoporosis include alendronate, ibandronate, risedronate and zoledronic acid. ► These bisphosphonates all reduce the level of bone turnover and increase the bone mineral density in postmenopausal osteoporosis. ► The bisphosphonates differ in their potency in their effects on bone turnover and bone density. ► The licensed bisphosphonates have all been shown to reduce the risk of vertebral fractures; some of them have also been shown to reduce the risk of non-vertebral and hip fractures.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Bone - Volume 49, Issue 1, July 2011, Pages 82-88
نویسندگان
, , , ,